purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Molecular Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Diseases
1.2.3 Oncology
1.2.4 Hematology and Endocrinology
1.3 Market by Application
1.3.1 Global POC Molecular Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global POC Molecular Diagnostics Market Perspective (2017-2028)
2.2 POC Molecular Diagnostics Growth Trends by Region
2.2.1 POC Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 POC Molecular Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 POC Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 POC Molecular Diagnostics Market Dynamics
2.3.1 POC Molecular Diagnostics Industry Trends
2.3.2 POC Molecular Diagnostics Market Drivers
2.3.3 POC Molecular Diagnostics Market Challenges
2.3.4 POC Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POC Molecular Diagnostics Players by Revenue
3.1.1 Global Top POC Molecular Diagnostics Players by Revenue (2017-2022)
3.1.2 Global POC Molecular Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global POC Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by POC Molecular Diagnostics Revenue
3.4 Global POC Molecular Diagnostics Market Concentration Ratio
3.4.1 Global POC Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Molecular Diagnostics Revenue in 2021
3.5 POC Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players POC Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into POC Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POC Molecular Diagnostics Breakdown Data by Type
4.1 Global POC Molecular Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global POC Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 POC Molecular Diagnostics Breakdown Data by Application
5.1 Global POC Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global POC Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America POC Molecular Diagnostics Market Size (2017-2028)
6.2 North America POC Molecular Diagnostics Market Size by Type
6.2.1 North America POC Molecular Diagnostics Market Size by Type (2017-2022)
6.2.2 North America POC Molecular Diagnostics Market Size by Type (2023-2028)
6.2.3 North America POC Molecular Diagnostics Market Share by Type (2017-2028)
6.3 North America POC Molecular Diagnostics Market Size by Application
6.3.1 North America POC Molecular Diagnostics Market Size by Application (2017-2022)
6.3.2 North America POC Molecular Diagnostics Market Size by Application (2023-2028)
6.3.3 North America POC Molecular Diagnostics Market Share by Application (2017-2028)
6.4 North America POC Molecular Diagnostics Market Size by Country
6.4.1 North America POC Molecular Diagnostics Market Size by Country (2017-2022)
6.4.2 North America POC Molecular Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe POC Molecular Diagnostics Market Size (2017-2028)
7.2 Europe POC Molecular Diagnostics Market Size by Type
7.2.1 Europe POC Molecular Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe POC Molecular Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe POC Molecular Diagnostics Market Share by Type (2017-2028)
7.3 Europe POC Molecular Diagnostics Market Size by Application
7.3.1 Europe POC Molecular Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe POC Molecular Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe POC Molecular Diagnostics Market Share by Application (2017-2028)
7.4 Europe POC Molecular Diagnostics Market Size by Country
7.4.1 Europe POC Molecular Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe POC Molecular Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific POC Molecular Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific POC Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific POC Molecular Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific POC Molecular Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific POC Molecular Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific POC Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific POC Molecular Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific POC Molecular Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific POC Molecular Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific POC Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific POC Molecular Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific POC Molecular Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America POC Molecular Diagnostics Market Size (2017-2028)
9.2 Latin America POC Molecular Diagnostics Market Size by Type
9.2.1 Latin America POC Molecular Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America POC Molecular Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America POC Molecular Diagnostics Market Share by Type (2017-2028)
9.3 Latin America POC Molecular Diagnostics Market Size by Application
9.3.1 Latin America POC Molecular Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America POC Molecular Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America POC Molecular Diagnostics Market Share by Application (2017-2028)
9.4 Latin America POC Molecular Diagnostics Market Size by Country
9.4.1 Latin America POC Molecular Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America POC Molecular Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POC Molecular Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa POC Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa POC Molecular Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa POC Molecular Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa POC Molecular Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa POC Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa POC Molecular Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa POC Molecular Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa POC Molecular Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa POC Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa POC Molecular Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa POC Molecular Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Molecular Diagnostics Introduction
11.1.4 Abbott Revenue in POC Molecular Diagnostics Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 bioMerieux
11.2.1 bioMerieux Company Details
11.2.2 bioMerieux Business Overview
11.2.3 bioMerieux POC Molecular Diagnostics Introduction
11.2.4 bioMerieux Revenue in POC Molecular Diagnostics Business (2017-2022)
11.2.5 bioMerieux Recent Developments
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher POC Molecular Diagnostics Introduction
11.3.4 Danaher Revenue in POC Molecular Diagnostics Business (2017-2022)
11.3.5 Danaher Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD POC Molecular Diagnostics Introduction
11.4.4 BD Revenue in POC Molecular Diagnostics Business (2017-2022)
11.4.5 BD Recent Developments
11.5 Certest Biotec
11.5.1 Certest Biotec Company Details
11.5.2 Certest Biotec Business Overview
11.5.3 Certest Biotec POC Molecular Diagnostics Introduction
11.5.4 Certest Biotec Revenue in POC Molecular Diagnostics Business (2017-2022)
11.5.5 Certest Biotec Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche POC Molecular Diagnostics Introduction
11.6.4 F. Hoffmann-La Roche Revenue in POC Molecular Diagnostics Business (2017-2022)
11.6.5 F. Hoffmann-La Roche Recent Developments
11.7 NeoGenomics
11.7.1 NeoGenomics Company Details
11.7.2 NeoGenomics Business Overview
11.7.3 NeoGenomics POC Molecular Diagnostics Introduction
11.7.4 NeoGenomics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.7.5 NeoGenomics Recent Developments
11.8 Bionano Genomics
11.8.1 Bionano Genomics Company Details
11.8.2 Bionano Genomics Business Overview
11.8.3 Bionano Genomics POC Molecular Diagnostics Introduction
11.8.4 Bionano Genomics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.8.5 Bionano Genomics Recent Developments
11.9 ExcitePCR
11.9.1 ExcitePCR Company Details
11.9.2 ExcitePCR Business Overview
11.9.3 ExcitePCR POC Molecular Diagnostics Introduction
11.9.4 ExcitePCR Revenue in POC Molecular Diagnostics Business (2017-2022)
11.9.5 ExcitePCR Recent Developments
11.10 Micronics
11.10.1 Micronics Company Details
11.10.2 Micronics Business Overview
11.10.3 Micronics POC Molecular Diagnostics Introduction
11.10.4 Micronics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.10.5 Micronics Recent Developments
11.11 Nimagen
11.11.1 Nimagen Company Details
11.11.2 Nimagen Business Overview
11.11.3 Nimagen POC Molecular Diagnostics Introduction
11.11.4 Nimagen Revenue in POC Molecular Diagnostics Business (2017-2022)
11.11.5 Nimagen Recent Developments
11.12 Novigenix
11.12.1 Novigenix Company Details
11.12.2 Novigenix Business Overview
11.12.3 Novigenix POC Molecular Diagnostics Introduction
11.12.4 Novigenix Revenue in POC Molecular Diagnostics Business (2017-2022)
11.12.5 Novigenix Recent Developments
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck POC Molecular Diagnostics Introduction
11.13.4 Merck Revenue in POC Molecular Diagnostics Business (2017-2022)
11.13.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer